scispace - formally typeset
M

Martine Guibourdenche

Researcher at Pasteur Institute

Publications -  15
Citations -  1099

Martine Guibourdenche is an academic researcher from Pasteur Institute. The author has contributed to research in topics: Neisseria meningitidis & Neisseria. The author has an hindex of 13, co-authored 15 publications receiving 961 citations.

Papers
More filters
Journal ArticleDOI

Supplement 2003-2007 (No. 47) to the White-Kauffmann-Le Minor scheme.

TL;DR: This supplement (no. 48) of the White-Kauffmann-Le Minor scheme reports on the characterization of 63 new Salmonella serovars and 25 new variants of previously described Salmonellas recognized by the WHO Collaborating Centre for Reference and Research on Salmonello between 2008 and 2010.
Journal ArticleDOI

CRISPR typing and subtyping for improved laboratory surveillance of Salmonella infections.

TL;DR: It was found that CRISPR polymorphism was strongly correlated with both serotype and multilocus sequence type, and spacer microevolution discriminated between subtypes within prevalent serotypes, making it possible to carry out typing and subtyping in a single step.
Journal ArticleDOI

High-Level Chloramphenicol Resistance in Neisseria meningitidis

TL;DR: The high-level chloramphenicol resistance that is described in N. meningitidis isolates is of great concern, since in developing countries, chlorampshenicol given intramuscularly is the standard therapy for meningococcal meningitis.
Journal ArticleDOI

Neisseria spp. and AIDS.

TL;DR: Neisseria meningitidis from various serogroups and two commensal neisseriae (N. sicca and N. perflava) were isolated from 15 patients at various stages of human immunodeficiency virus infection in this clinical and bacteriological study.
Journal ArticleDOI

Production of polyclonal and monoclonal antibodies against group A, B, and C capsular polysaccharides of Neisseria meningitidis and preparation of latex reagents.

TL;DR: Polyclonal and monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, B, and C were produced in order to develop immunological reagents allowing both the detection of soluble antigens during meningococcal meningitis and antigenic serogrouping of N. mening itidis cultures.